Clinical Trials
7 trialsNCT06484361 2024-07-03
PET/MRI to Stage Prostate Cancer Patients
IRCCS San Raffaele
Phase 2 Recruiting
NCT04264208 2024-02-01
HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer
Stanford University
Phase 2 Terminated
NCT03809078 2024-01-11
68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
Stanford University
Phase 2 Completed
NCT03113617 2023-12-12
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer
Stanford University
Phase 2 Completed
NCT05806853 2023-04-10
PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study
IRCCS San Raffaele
Phase 2 Completed
NCT02559115 2021-05-18
68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02440308 2017-04-11
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer
Stanford University
Phase 2 Completed